[go: up one dir, main page]

IT1271461B - ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE. - Google Patents

ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE.

Info

Publication number
IT1271461B
IT1271461B ITFI930246A ITFI930246A IT1271461B IT 1271461 B IT1271461 B IT 1271461B IT FI930246 A ITFI930246 A IT FI930246A IT FI930246 A ITFI930246 A IT FI930246A IT 1271461 B IT1271461 B IT 1271461B
Authority
IT
Italy
Prior art keywords
production
egfr monoclonal
body antibody
antibody
monoclonal anti
Prior art date
Application number
ITFI930246A
Other languages
Italian (it)
Inventor
Antonio Mele
Santis Rita De
Marsal Cristina Ferrer
Original Assignee
Menarini Ricerche Sud Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Sud Spa filed Critical Menarini Ricerche Sud Spa
Priority to ITFI930246A priority Critical patent/IT1271461B/en
Publication of ITFI930246A0 publication Critical patent/ITFI930246A0/en
Priority to AU12417/95A priority patent/AU1241795A/en
Priority to PCT/EP1994/003995 priority patent/WO1995016037A1/en
Publication of ITFI930246A1 publication Critical patent/ITFI930246A1/en
Application granted granted Critical
Publication of IT1271461B publication Critical patent/IT1271461B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2809—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against the T-cell receptor (TcR)-CD3 complex
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ITFI930246A 1993-12-01 1993-12-01 ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE. IT1271461B (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITFI930246A IT1271461B (en) 1993-12-01 1993-12-01 ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE.
AU12417/95A AU1241795A (en) 1993-12-01 1994-12-01 Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use
PCT/EP1994/003995 WO1995016037A1 (en) 1993-12-01 1994-12-01 Anti-egf-r/anti-cd3 bispecific monoclonal antibody, method for its production and its use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI930246A IT1271461B (en) 1993-12-01 1993-12-01 ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE.

Publications (3)

Publication Number Publication Date
ITFI930246A0 ITFI930246A0 (en) 1993-12-01
ITFI930246A1 ITFI930246A1 (en) 1995-06-01
IT1271461B true IT1271461B (en) 1997-05-28

Family

ID=11350667

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI930246A IT1271461B (en) 1993-12-01 1993-12-01 ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE.

Country Status (3)

Country Link
AU (1) AU1241795A (en)
IT (1) IT1271461B (en)
WO (1) WO1995016037A1 (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6018031A (en) * 1989-10-20 2000-01-25 Trustees Of Dartmouth College Binding agents specific for IgA receptor
ATE232902T1 (en) * 1994-03-17 2003-03-15 Merck Patent Gmbh ANTI-EGFR SINGLE CHAIN FVS AND ANTI-EGFR ANTIBODIES
US5846782A (en) 1995-11-28 1998-12-08 Genvec, Inc. Targeting adenovirus with use of constrained peptide motifs
US5559099A (en) * 1994-09-08 1996-09-24 Genvec, Inc. Penton base protein and methods of using same
US6465253B1 (en) 1994-09-08 2002-10-15 Genvec, Inc. Vectors and methods for gene transfer to cells
US5770442A (en) * 1995-02-21 1998-06-23 Cornell Research Foundation, Inc. Chimeric adenoviral fiber protein and methods of using same
US6127525A (en) * 1995-02-21 2000-10-03 Cornell Research Foundation, Inc. Chimeric adenoviral coat protein and methods of using same
US6783980B2 (en) 1995-06-15 2004-08-31 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
US5922845A (en) 1996-07-11 1999-07-13 Medarex, Inc. Therapeutic multispecific compounds comprised of anti-Fcα receptor antibodies
US20030017138A1 (en) 1998-07-08 2003-01-23 Menzo Havenga Chimeric adenoviruses
US6929946B1 (en) 1998-11-20 2005-08-16 Crucell Holland B.V. Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
US6492169B1 (en) 1999-05-18 2002-12-10 Crucell Holland, B.V. Complementing cell lines
US6913922B1 (en) 1999-05-18 2005-07-05 Crucell Holland B.V. Serotype of adenovirus and uses thereof
US7235233B2 (en) 2000-09-26 2007-06-26 Crucell Holland B.V. Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
US7595378B2 (en) 2001-06-13 2009-09-29 Genmab A/S Human monoclonal antibodies to epidermal growth factor receptor (EGFR)
IL159225A0 (en) 2001-06-13 2004-06-01 Genmab As Human monoclonal antibodies to epidermal growth factor receptor (egfr)
CN100497639C (en) 2002-04-25 2009-06-10 克鲁塞尔荷兰公司 Means and methods for the production of adenovirus vectors
JP3803790B2 (en) 2003-02-17 2006-08-02 株式会社東北テクノアーチ Novel diabody-type bispecific antibody
TWI391399B (en) 2005-05-25 2013-04-01 Hoffmann La Roche Method for determining the concentration of a salt for eluting a polypeptide
AU2006301492B2 (en) * 2005-10-11 2011-06-09 Amgen Research (Munich) Gmbh Compositions comprising cross-species-specific antibodies and uses thereof
HRP20120759T1 (en) * 2007-04-03 2012-10-31 Amgen Research (Munich) Gmbh Cross-species-specific bispecific binders
RU2009148891A (en) 2007-06-01 2011-07-20 Ф.Хоффманн-Ля Рош Аг (Ch) IMMUNOGLOBULIN CLEANING
CN101307109B (en) * 2008-06-04 2010-11-17 张传林 Mouse-anti-human T lymphocyte CD3 surface antigen monoclonal antibodies, method for preparing same and use
BRPI0923541A2 (en) 2008-12-22 2016-01-26 Hoffmann La Roche immunoglobulin purification
DK3024851T3 (en) 2013-07-25 2018-08-06 Cytomx Therapeutics Inc MULTI-SPECIFIC ANTIBODIES, MULTI-SPECIFICALLY ACTIVABLE ANTIBODIES, AND METHODS FOR USING IT
KR20170010863A (en) 2014-07-01 2017-02-01 화이자 인코포레이티드 Bispecific heterodimeric diabodies and uses thereof
WO2016014974A2 (en) 2014-07-25 2016-01-28 Cytomx Therapeutics, Inc. Anti-cd3 antibodies, activatable anti-cd3 antibodies, multispecific anti-cd3 antibodies, multispecific activatable anti-cd3 antibodies, and methods of using the same
EP3694885A1 (en) 2017-10-14 2020-08-19 CytomX Therapeutics, Inc. Antibodies, activatable antibodies, bispecific antibodies, and bispecific activatable antibodies and methods of use thereof
CN116368154A (en) 2020-10-08 2023-06-30 阿菲姆德股份有限公司 trispecific binder
WO2023007023A1 (en) 2021-07-30 2023-02-02 Affimed Gmbh Duplexbodies

Also Published As

Publication number Publication date
ITFI930246A0 (en) 1993-12-01
WO1995016037A1 (en) 1995-06-15
ITFI930246A1 (en) 1995-06-01
AU1241795A (en) 1995-06-27

Similar Documents

Publication Publication Date Title
IT1271461B (en) ANTI-CD3 / ANTI-EGFR MONOCLONAL ANTI-BODY ANTIBODY, PROCESS FOR PRODUCTION AND ITS USE.
BR9606706A (en) Bispecific or bivalent antibody fragment analog use process to produce the same
NO924279D0 (en) LYOPHILIZED, MONOCLONAL ANTIBODY PREPARATION
NO955167L (en) Monoclonal anti-V integrin antibody
EP0618929A4 (en) Bispecific antibody heterodimers.
DE68914244D1 (en) Monoclonal antibody.
EP0671951A4 (en) HUMANIZED ANTIBODIES THAT REACT WITH 1-SELECTECT.
FI963004A7 (en) Monoclonal antibodies that stimulate antibody formation
FI964845A7 (en) Anti-CD44v6 monoclonal antibodies
EP0578515A3 (en) Humanized monoclonal antibodies.
DK557289D0 (en) MONOCLONAL, FUCOSYL CERAMID-RECOGNIZING ANTIBODY, ITS MANUFACTURING AND USE, AND HYBRIDOMA FOR THE MANUFACTURING
DE59608073D1 (en) ANTIBODIES AGAINST A FUSION POLYPEPTIDE HAVING A HISTIDINE PART
KR950700390A (en) Reinforced hydrocarbon, manufacturing method and use method (FORTIFIED HYDROCARBON AND PROCESS FOR MAKING AND USING THE SAME)
FI885169L (en) Monoclonal antibody recognizing N-acetylneuraminic acid in the sequence, its use and hybridoma producing it
FI945877L (en) Method for producing protein C
FI934963A7 (en) CTAA 81AV78, antigen recognized by the 81AV78 human monoclonal antibody
EP0554458A4 (en) Immunoassay, monoclonal antibody and hybridoma
NO890116D0 (en) MONOCLONAL ANTIBODIES.
EP0667395A4 (en) Monoclonal antibody, process for producing the same, and use thereof.
EP0581108A3 (en) Bispecific antibody that reacts with sialyl-lea antigen and CD3.
NO894555L (en) MONOCLONAL ANTIBODY THAT SPECIFICALLY RECOGNIZES N-GLYCOLYL TYPE GM2, HYBRIDOM THAT PRODUCES ANTIBODY AND PROCEDURE FOR PRODUCING THE HYBRIDOM.
IT8821702A0 (en) NEW MONOCLONAL ANTIBODY.
EP0654532A4 (en) Antimucoglycoprotein monoclonal antibody.
FI960566L (en) Monoclonal antibody that recognizes interstitial cell surface antigen
DE69020315D1 (en) MONOCLONAL ANTIBODY AGAINST C-REACTIVE PROTEIN.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961230